New Florida rules advise against drugs for depression, anxiety for kids

The Florida Department of Health recently released new guidelines advising against the use of psychotropic medications for children and adolescents aged 5 to 17. The guidance suggests that drugs intended to treat conditions like depression, anxiety, and attention-deficit disorders should not be the primary course of action in most cases. Instead, the state is encouraging clinicians to prioritize psychotherapy and behavior management techniques.

State Surgeon General Dr. Joseph A. Ladapo stated that treatment must focus on the unique circumstances of each child. The department is urging healthcare providers to carefully weigh the risks and benefits of pharmaceutical intervention before choosing to prescribe medication. This shift aligns with broader discussions currently taking place at the national level regarding childhood healthcare practices.

This move by Florida officials mirrors priorities shared by federal health leadership regarding the oversight of psychiatric drugs for minors. The guidance explicitly cautions against relying on medication as a substitute for individual therapy or other psychosocial care options. According to the state, the goal is to ensure that children receive thorough clinical assessments and that parents remain well-informed about the alternatives to traditional medication.

While the state maintains that its guidance is meant to increase awareness and improve clinical oversight, it has drawn attention from professional medical organizations. Critics argue that broad challenges to established psychiatric practices may carry risks for patients requiring specific care. The state maintains that its position does not contradict standard clinical recommendations but emphasizes the need for a more cautious approach to prescribing.